Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1416 (LINC01416)
- Target
- LINC01416
- Molecular classification
- Long intergenic noncoding RNA (lincRNA), Non-coding RNA, Other
01
Overview
Long intergenic non-protein coding RNA 1416 (LINC01416) is an annotated long intergenic noncoding RNA gene. LINC01416 is transcribed from a region of the genome that does not overlap protein-coding genes; its transcript is longer than 200 nucleotides. LINC01416 is presumed to regulate gene expression and may influence basic biological processes such as cell differentiation, development, and cellular homeostasis. Like other lincRNAs, dysregulation may be linked to disease, including tumorigenesis and possibly neurodegenerative or autoimmune disorders, although there is currently no specific published evidence describing its exact biological role, disease association, or use in therapeutic targeting. No direct clinical or experimental links have been established with drugs, biomarkers, or notable therapeutic challenges.
- Other names
- LINC01416Long intergenic non-protein coding RNA 1416
02
Biological functions
Regulation of gene expressionPotential role in cell differentiation and cell developmentMay be involved in cellular homeostasis and modulating disease processes, though specific validated functions of LINC01416 itself are not detailed in the literature
03
Disease associations
Cancer (lincRNAs as a class are implicated in tumorigenesis and progression, but LINC01416-specific evidence is limited in current literature; nearby listings discuss other lincRNAs such as LINC01614 and their role in cancer and metastasis)Other (potential roles in autoimmune diseases and neurodegeneration for lincRNAs as a class, but specific direct evidence for LINC01416 not found)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1416 (LINC01416).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1416 (LINC01416).